Production (Stage)
Tonix Pharmaceuticals Holding Corp.
TNXP
$28.93
$2.539.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.04% | 29.94% | 183.05% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.04% | 29.94% | 183.05% | -- | -- |
| Cost of Revenue | 10.11% | 63.78% | 276.96% | -- | -- |
| Gross Profit | -22.24% | -23.06% | 45.02% | -- | -- |
| SG&A Expenses | 11.52% | 15.40% | 15.90% | 24.39% | 23.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.94% | -30.37% | -26.52% | -14.04% | -2.91% |
| Operating Income | 31.54% | 34.33% | 33.27% | 23.99% | 11.48% |
| Income Before Tax | -33.81% | -11.47% | -11.76% | -22.12% | 15.59% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -33.81% | -11.47% | -11.76% | -22.12% | 15.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.81% | -11.47% | -11.76% | -22.12% | 15.59% |
| EBIT | 31.54% | 34.33% | 33.27% | 23.99% | 11.48% |
| EBITDA | 31.47% | 34.89% | 34.58% | 25.82% | 13.67% |
| EPS Basic | 27.68% | -14.54% | -- | -- | -- |
| Normalized Basic EPS | 2.88% | -- | -- | -- | -- |
| EPS Diluted | 27.68% | -14.54% | -- | -- | -- |
| Normalized Diluted EPS | 2.88% | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 31,630.47% | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 21,812.87% | 23,528.00% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |